Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-9-5
pubmed:abstractText
Resistance of Bcr-Abl-positive leukemic stem cells (LSCs) to imatinib treatment in patients with chronic myeloid leukemia (CML) can cause relapse of disease and might be the origin for emerging drug-resistant clones. In this study, we identified Smo as a drug target in Bcr-Abl-positive LSCs. We show that Hedgehog signaling is activated in LSCs through upregulation of Smo. While Smo(-/-) does not impact long-term reconstitution of regular hematopoiesis, the development of retransplantable Bcr-Abl-positive leukemias was abolished in the absence of Smo expression. Pharmacological Smo inhibition reduced LSCs in vivo and enhanced time to relapse after end of treatment. Our results indicate that Smo inhibition might be an effective treatment strategy to reduce the LSC pool in CML.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/4-methyl-N-(3-(4-methylimidazol-1-yl..., http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl, http://linkedlifedata.com/resource/pubmed/chemical/Gli protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Hedgehog Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Kruppel-Like Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, G-Protein-Coupled, http://linkedlifedata.com/resource/pubmed/chemical/Smo protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Veratrum Alkaloids, http://linkedlifedata.com/resource/pubmed/chemical/cyclopamine, http://linkedlifedata.com/resource/pubmed/chemical/patched receptors
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1878-3686
pubmed:author
pubmed:issnType
Electronic
pubmed:day
9
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
238-49
pubmed:dateRevised
2009-5-20
pubmed:meshHeading
pubmed-meshheading:18772113-Animals, pubmed-meshheading:18772113-Apoptosis, pubmed-meshheading:18772113-Bone Marrow Cells, pubmed-meshheading:18772113-Bone Marrow Transplantation, pubmed-meshheading:18772113-Cell Proliferation, pubmed-meshheading:18772113-Drug Therapy, Combination, pubmed-meshheading:18772113-Fetal Stem Cells, pubmed-meshheading:18772113-Fusion Proteins, bcr-abl, pubmed-meshheading:18772113-Gene Expression, pubmed-meshheading:18772113-Hedgehog Proteins, pubmed-meshheading:18772113-Hematopoiesis, pubmed-meshheading:18772113-Humans, pubmed-meshheading:18772113-Kruppel-Like Transcription Factors, pubmed-meshheading:18772113-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:18772113-Mice, pubmed-meshheading:18772113-Mice, Inbred C57BL, pubmed-meshheading:18772113-Mice, Knockout, pubmed-meshheading:18772113-Mice, Transgenic, pubmed-meshheading:18772113-Neoplastic Stem Cells, pubmed-meshheading:18772113-Pyrimidines, pubmed-meshheading:18772113-Receptors, Cell Surface, pubmed-meshheading:18772113-Receptors, G-Protein-Coupled, pubmed-meshheading:18772113-Signal Transduction, pubmed-meshheading:18772113-Survival Analysis, pubmed-meshheading:18772113-Veratrum Alkaloids
pubmed:year
2008
pubmed:articleTitle
Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation.
pubmed:affiliation
Department of Hematology/Oncology, University of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany. christine.dierks@uniklinik-freiburg.de
pubmed:publicationType
Journal Article